BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33757771)

  • 1. Magnetic-core-based silibinin nanopolymeric carriers for the treatment of renal cell cancer.
    Takke A; Shende P
    Life Sci; 2021 Jun; 275():119377. PubMed ID: 33757771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained release of silibinin-loaded chitosan nanoparticle induced apoptosis in glioma cells.
    Alipour M; Reza Bigdeli M; Aligholi H; Rasoulian B; Khaksarian M
    J Biomed Mater Res A; 2020 Mar; 108(3):458-469. PubMed ID: 31657514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, purification, and anticancer effect of magnetic Fe
    Wang K; Hu H; Zhang Q; Zhang Y; Shi C
    J Microencapsul; 2019 Jun; 36(4):356-370. PubMed ID: 31190597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silibinin encapsulation in polymersome: A promising anticancer nanoparticle for inducing apoptosis and decreasing the expression level of miR-125b/miR-182 in human breast cancer cells.
    Hossainzadeh S; Ranji N; Naderi Sohi A; Najafi F
    J Cell Physiol; 2019 Dec; 234(12):22285-22298. PubMed ID: 31073992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of sorafenib-loaded poly (lactic/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinoma.
    Liu J; Boonkaew B; Arora J; Mandava SH; Maddox MM; Chava S; Callaghan C; He J; Dash S; John VT; Lee BR
    J Pharm Sci; 2015 Mar; 104(3):1187-96. PubMed ID: 25573425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity of Paclitaxel in biodegradable self-assembled core-shell poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles.
    He X; Ma J; Mercado AE; Xu W; Jabbari E
    Pharm Res; 2008 Jul; 25(7):1552-62. PubMed ID: 18196205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.
    Li Y; Pei Y; Zhang X; Gu Z; Zhou Z; Yuan W; Zhou J; Zhu J; Gao X
    J Control Release; 2001 Apr; 71(2):203-11. PubMed ID: 11274752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer Potential of Silibinin Loaded Polymeric Nanoparticles against Breast Cancer Cells: Insight into the Apoptotic Genes Targets.
    Pourgholi A; Dadashpour M; Mousapour A; Firouzi Amandi A; Zarghami N
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2587-2596. PubMed ID: 34452574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
    Feng SS; Mu L; Win KY; Huang G
    Curr Med Chem; 2004 Feb; 11(4):413-24. PubMed ID: 14965222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Magnetic Nanostructure for Co-delivery of Metformin and Silibinin on Growth of Lung Cancer Cells: Possible Action Through Leptin Gene and its Receptor Regulation.
    Salmani Javan E; Lotfi F; Jafari-Gharabaghlou D; Mousazadeh H; Dadashpour M; Zarghami N
    Asian Pac J Cancer Prev; 2022 Feb; 23(2):519-527. PubMed ID: 35225464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication, characterization and bioevaluation of silibinin loaded chitosan nanoparticles.
    Pooja D; Babu Bikkina DJ; Kulhari H; Nikhila N; Chinde S; Raghavendra YM; Sreedhar B; Tiwari AK
    Int J Biol Macromol; 2014 Aug; 69():267-73. PubMed ID: 24863917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of anti-cancer potency of silibinin on murine renal carcinoma RenCa cells in an animal model with an intact immune system.
    Yang C; Li F; Ma J; Zhang HB; Jia J; Zeng J; Wang X; He D; Guo P
    Anticancer Drugs; 2020 Sep; 31(8):785-791. PubMed ID: 32209841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer.
    Mahira S; Kommineni N; Husain GM; Khan W
    Biomed Pharmacother; 2019 Feb; 110():803-817. PubMed ID: 30554119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silibinin loaded inhalable solid lipid nanoparticles for lung targeting.
    Patel P; Raval M; Airao V; Bhatt V; Shah P
    J Microencapsul; 2022 Jan; 39(1):1-24. PubMed ID: 34825627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silibinin-loaded magnetic nanoparticles inhibit hTERT gene expression and proliferation of lung cancer cells.
    Amirsaadat S; Pilehvar-Soltanahmadi Y; Zarghami F; Alipour S; Ebrahimnezhad Z; Zarghami N
    Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1649-1656. PubMed ID: 28078913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and
    Akhter MH; Kumar S; Nomani S
    Drug Dev Ind Pharm; 2020 Apr; 46(4):659-672. PubMed ID: 32208984
    [No Abstract]   [Full Text] [Related]  

  • 17. Plumbagin-loaded aptamer-targeted poly D,L-lactic-co-glycolic acid-b-polyethylene glycol nanoparticles for prostate cancer therapy.
    Pan M; Li W; Yang J; Li Z; Zhao J; Xiao Y; Xing Y; Zhang X; Ju W
    Medicine (Baltimore); 2017 Jul; 96(30):e7405. PubMed ID: 28746182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silibinin-Loaded Nanostructured Lipid Carriers for Growth Inhibition of Cisplatin-Resistant Ovarian Cancer Cells.
    Jafari S; Bakhshaei A; Eskandani M; Molavi O
    Assay Drug Dev Technol; 2022 Dec; 20(8):339-348. PubMed ID: 36383148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.